ac

Diabetes mellitus and renal failure effect on intestinal insulin

Penulis

  • Asrar Ali Department of Human Nutrition and Dietetics, Nishtar Medical University Multan
  • Noor-Alhooda M Al-Awkally Medical Laboratory Department, Higher Institute of Science and Technology, Sulug
  • Areeb Ahmer Faculty of Veterinary and Animal Sciences, MNS University of Agriculture, 66000, Multan, Pakistan
  • Sania Tariq Faculty of Veterinary and Animal Sciences, MNS University of Agriculture, 66000, Multan, Pakistan
  • Talha Mumtaz Faculty of Veterinary and Animal Sciences, MNS University of Agriculture, 66000, Multan, Pakistan
  • Huma Shahbaz Kings College of Health sciences Sahiwal
  • Rabbya Rayan Shah Faculty of Veterinary and Animal Sciences, MNS University of Agriculture, 66000, Multan, Pakistan

DOI:

10.47709/brilliance.v2i3.1600

Kata Kunci:

World Kidney Day, diabetes mellitus (DM), chronic kidney disease

Dimension Badge Record



Abstrak

The two most prevalent causes of end-stage renal disease nowadays are thought to be diabetic mellitus (DM) and hypertension (ESRD). In addition to discussing the function of DM in ESRD, this study reviews glucose metabolism and the treatment of hyperglycemia in these patients. Although strict glycemic control and ESRD patient survival were not significantly correlated in numerous big trials, it is advised that glycemic control be prioritised as the primary therapeutic objective in the care of these patients to minimise harm to other organs. When fasting blood sugar is less than 140 mg/dL, 1-hour postprandial blood sugar is less than 200 mg/dL, and glycosylated haemoglobin (HbA1c) is 6-7 in type 1 diabetes patients and 7-8 in type 2 diabetes patients, glycemic control is ideal. Given its potentially deadly side effect, lactic acidosis, metformin administration should be avoided in patients with chronic renal failure (CRF), while glipizide and repaglinide seem to be preferable options.

Google Scholar Cite Analysis
Abstrak viewed = 248 times

Referensi

Arif, S., Zia, T., Qayyum, Z., Mustafa, G., Ateeq, M., Farhad, S., ... & Muthanna, F. M. (2022). Prevalence and Risk Factors of Covid-19 Mortality and its Impact on Social Life of Pakistani Population. Pakistan Journal of Medical & Health Sciences, 16(03), 800-800.

Arif, S., Zia, T., Mustafa, G., Qayyum, Z., Ateeq, M., Faiz, M. J., ... & Ullah, I. (2022). Knowledge, Attitude and Practices of Medical Students Regarding Covid-19, Pakistan. Pakistan Journal of Medical & Health Sciences, 16(03), 783-783.

Muthanna, F. M., & Samad, A. (2022). Covid-19 Pendemic (Incidence, Risk factors and Treatment). BULLET: Jurnal Multidisiplin Ilmu, 1(01), 46-48.

Muthanna, F. M., Ibrahim, H. K., Al-Awkally, N.-A. M., Yousuf, A., & Mounich, K. (2022). C-reactive protein in patients with COVID-19: A scoping review. International Journal of Health Sciences, 6(S5), 1610–1620. https://doi.org/10.53730/ijhs.v6nS5.8920

Al-Awkally, Noor-Alhooda Milood, Hamza Khalifa Ibrahim, and Abdul Samad. "Antipsychotic Combinations for Psychiatric Disorders." BULLET: Jurnal Multidisiplin Ilmu 1.01 (2022): 49-50

Samad, A., Ahmad, H., Hamza, M., Muazzam, A., Ahmer, A., Tariq, S & Muthanna, F. M. (2022). Overview of Avian Corona virus, its prevention and control Measures. BULLET: Jurnal Multidisiplin Ilmu, 1(01), 39-45.

Samad, A. ., Hamza , M., Muazzam, A. ., Ahmad, H. ., Ahmer, A. ., Tariq, S. ., Khera, H. U. R. A. ., Mehtab, U. ., Shahid, M. J. ., Akram, W. ., Kaleem, M. Z. ., Ahmad, S. ., Abdullah, A. ., & Ahmad, S. . (2022). Policy of control and prevention of infectious bursal disease at poultry farm. African Journal of Biological, Chemical and Physical Sciences, 1(1), 1-7.

Samad A, Abbas A, Mehtab U, Ur Rehman Ali Khera H, Rehman A and Hamza M . Infectious Bronchitis Disease in Poultry its Diagnosis, Prevention and Control Strategies. Ann Agric Crop Sci. 2021; 6(7): 1100.

Samad, A., Hamza, M., Muazzam, A., Ahmer, A., Tariq, S., Javaid, A., ... & Ahmad, S. (2022). Newcastle Disease In Poultry, Its Diagnosis, Prevention And Control Strategies. BULLET: Jurnal Multidisiplin Ilmu, 1(01), 1-5.

Mohammed, A. A., Samad, A., & Omar, O. A. (2022). Escherichia coli spp, Staph albus and Klebseilla spp were affected by some Antibiotics for Urinary Tract Infections in Bani Waleed City. Brilliance: Research of Artificial Intelligence, 2(2), 66-70.

Samad, A., Hamza, M., Muazzam, A., Ahmer, A., Tariq, S., Shahid, M. J., ... & Din, F. U. (2022). Overview of Bacterial Diseases in Poultry and policies to control disease and antibiotic resistance. BULLET: Jurnal Multidisiplin Ilmu, 1(01), 19-25.

Abboud H, Henrich WL. Clinical practice. Stage IV chronic kidney disease. N Engl J Med 2010;362:56-65.

Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age. Kidney Int 2006;69:375-82.

Ardalan MR, Nasri H. Lessons from our paleolithic primogenitors; a short look to the world diabetes day 2014 with the theme of “healthy living and diabetes”. J Parathyr Dis 2014;2:57-8.

Rahimi Z, Mansouri Zaveleh O, Rahimi Z, Abbasi A. AT2R -1332 G: A polymorphism and diabetic nephropathy in type 2 diabetes mellitus patients. J Renal Inj Prev 2013;2:97-101.

Einollahi B. Are acquired cystic kidney disease and autosomal dominant polycystic kidney disease risk factors for renal cell carcinoma in kidney transplant patients? J Nephropathol 2012;1:65-8.

Golshahi J, Nasri H, Gharipour M. Contrast-induced nephropathy; a literature review. J Nephropathol 2014;3:51-6.

Moradi M, Rahimi Z, Amiri S, Rahimi Z, Vessal M, Nasri H. AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy. J Nephropathol 2015;4:69-76.

Arashnia R, Roohi-Gilani K, Karimi-Sari H, Nikjoo N, Bahramifar A. Effect of pioglitazone therapy on high sensitive C-reactive protein and lipid profile in diabetic patients with renal transplantation; a randomize clinical trial. J Nephropathol 2015;4:48-53.

Nasri H, Ghorbani A. Does erythropoietin slow progression of chronic kidney disease? J Renal Inj Prev 2013;2:81-2.

Roozbeh J, Sagheb MM, Vafaie E. The association between blood pressure level and serum uric acid concentration in hemodialysis patients. J Nephropathol 2015;4:85-90.

Tamadon MR, Zahmatkesh M. World kidney day 2015. J Parathyr Dis 2015;3:34-6.

Kari J. Epidemiology of chronic kidney disease in children. J Nephropathol 2012;1:162-3.

Tamadon MR, Ardalan MR, Nasri H. World Kidney Day 2013; acute renal injury; a global health warning. J Parathyr Dis 2013;1:27-8.

Assadi F. Psychological impact of chronic kidney disease among children and adolescents: Not rare and not benign. J Nephropathol 2013;2:1-3.

Junaid Nazar CM, Kindratt TB, Ahmad SM, Ahmed M, Anderson J. Barriers to the successful practice of chronic kidney diseases at the primary health care level; a systematic review. J Renal Inj Prev 2014;3:61-7.

Motamedi P, Dehghani N, Kiani F, Taheri Z, Torkamaneh S, Nasri H. New concepts in diabetic kidney disease. J Nephropharmacol 2015;4:47-8.

Nasri H. The awareness of chronic kidney disease and aging; the focus of world kidney day in 2014. J Nephropharmacol 2014;3:1-2.

Hernandez GT, Nasri H. World Kidney Day 2014: Increasing awareness of chronic kidney disease and aging. J Renal Inj Prev 2013;3:3-4.

USRDS: The United States Renal Data System. Excerpts from the USRDS 2009 annual data report: Atlas of end- stage renal disease in the United States. Am J Kidney Dis 2010;55(Suppl 1):S1.

Ardalan MR, Sanadgol H, Nasri H, Baradaran A, Tamadon MR, Rafieian-Kopaei R. Vitamin D therapy in diabetic kidney disease;

current knowledge on a public health problem. J Parathyr Dis 2014;2:15-7.

Sechi LA, Catena C, Zingaro L, Melis A, De Marchi S. Abnormalities of glucose metabolism in patients with early renal failure. Diabetes 2002;51:1226-32.

Einollahi B, Motalebi M, Salesi M, Ebrahimi M, Taghipour M. The impact of cytomegalovirus infection on new-onset diabetes mellitus after kidney transplantation: A review on current findings. J Nephropathol 2014;3:139-48.

Hajivandi A, Amiri M. World diabetes day 2013: Diabetes mellitus and nephrology. J Nephropharmacol 2013;2:31-2.

Rafieian-Kopaie M, Nasri H. Silymarin and diabetic nephropathy. J Renal Inj Prev 2012;1:3-5.

Tolouian R, T Hernandez G. Prediction of diabetic nephropathy: The need for a sweet biomarker. J Nephropathol 2013;2:4-5.

Baradaran A, Mardani S, Tamadon MR, Shahbazian H, Beladi Mousavi SS. Sevelamer, a phosphate-binding resin with beneficial effect in diabetic kidney disease; a modern paradigm shift. J Parathyr Dis 2014;2:61-2.

Andrianesis V, Doupis J. The role of kidney in glucose homeostasis--SGLT2 inhibitors, a new approach in diabetes treatment. Expert Rev Clin Pharmacol 2013;6:519-39.

Nasri H. Consequences of hypomagnesemia in type 2 diabetes mellitus patients. J Renal Inj Prev 2014;3:99-100.

Shahbazian H, Rezaii I. Diabetic kidney disease; review of the current knowledge. J Renal Inj Prev 2013;2:73-80.

Nasri H, Behradmanesh S, Ahmadi A, Baradaran A, Nasri P, Rafieian-Kopaei M. Association of serum lipids with level of blood pressure in type 2 diabetic patients. J Renal Inj Prev 2013;3:43-6.

Rafieian-Kopaei M, Nasri H. Vitamin D therapy in diabetic kidney disease. Nephropharmacol 2014;3:3-4.

Mirhoseini M, Baradaran A, Rafieian-Kopaei M. Medicinal plants, diabetes mellitus and urgent needs. J HerbMed Pharmacol 2013;2:53-4.

Sadia Farhad, Inam-U-Llah, K. Suresh Babu, Sidra Wali, Bushra Tahreem, Izba Amjad, Sana Khalid, Fares Mohammed Saeed Muthanna . Detection of Anti-Erythropoietin Antibodies in Patients with Chronic Renal Failure Undergoing Hemodialysis; pjmhsonline.com. Retrieved Jan 25, 2022, from https://pjmhsonline.com/published-issues/2022/January/1-1256

Muthanna, F. M., Samad, A., Ibrahim, H. K., Al-Awkally, N. A. M., & Sabir, S. (2022). Cancer related anaemia (CRA): An overview of approach and treatment. International Journal of Health Sciences, 6, 2552-2558.

##submission.downloads##

ARTICLE Diterbitkan HISTORY

Submitted Date: 2022-07-08
Accepted Date: 2022-07-08
Published Date: 2022-07-08

Cara Mengutip

Ali, A., Al-Awkally, N.-A. M. ., Ahmer, A. ., Tariq, S., Mumtaz, T., Shahbaz, H. ., & Shah, R. R. . (2022). Diabetes mellitus and renal failure effect on intestinal insulin. Brilliance: Research of Artificial Intelligence, 2(3), 102-106. https://doi.org/10.47709/brilliance.v2i3.1600